Preclinical characterization of pharmacological NAD + boosting as a promising therapeutic approach in Rheumatoid Arthritis.
Carlos Perez-SanchezAlejandro Escudero-ContrerasTomás CerdóLuz Marina Sánchez-MendozaAdrián Llamas-UrbanoIván Arias-de la RosaMiguel Pérez-RodriguezLaura Muñoz-BarreraMaría Del Carmen Abalos-AguileraNuria BarbarrojaJerusalem CalvoRafaela Ortega-CastroDesiree Ruiz-VilchesJuan Antonio MorenoMaría Isabel BurónJosé Antonio González-ReyesEduardo Collantes-EstevezRosario Lopez-PedreraJosé Manuel VillalbaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
boosters in RA-leukocytes, along with their proven clinical safety, might pave the way for the development of clinical trials using these compounds. This article is protected by copyright. All rights reserved.